166 results on '"Bouscary, Didier"'
Search Results
2. FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells
3. Accuracy and safety of 101 consecutives neurosurgical procedures for newly diagnosed central nervous system lymphomas: a single-institution experience
4. Supplementary Figure 7 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
5. Supplementary Figure 1 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
6. Supplementary Figure 8 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
7. Supplementary Figure 2 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
8. Supplementary Table 2 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
9. Supplementary Table 1 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
10. Movie Sup 1.TAS cells have greater migratory capacity than untreated T cells in viable Capan-2 tumors explant. from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
11. Supplementary Figure 3 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
12. Data from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
13. Supplementary Figure 6 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
14. Supplementary Figure 4 from FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
15. RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia
16. Pediatric Plasma Cell Neoplasms: A Population-Based Study
17. Antimicrobial stewardship in high-risk febrile neutropenia patients
18. Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell level
19. Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells
20. Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients
21. Evolution of radiotherapy techniques for mediastinal Hodgkin lymphoma: a single-center experience
22. Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma Patients
23. Successful nelarabine and venetoclax treatment of a relapsed/refractory mediastinal myeloid sarcoma with clonal TCR rearrangement
24. FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors
25. Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM)
26. S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
27. Data from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3-Mutant Leukemia
28. Supplementary Information v.2 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3-Mutant Leukemia
29. Supplementary Figures S1-S22 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3-Mutant Leukemia
30. Clinico‐biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi‐centric observational study
31. Supplementary Table S15 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3-Mutant Leukemia
32. Management of Gastro-Intestinal Toxicity of the Pi3 Kinase Inhibitor: Optimizing Future Dosing Strategies
33. C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis inFLT3-Mutant Leukemia
34. Supplementary Figure Legend, Table 1 from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
35. Supplementary Figures 1 - 4 from Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
36. Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective study
37. In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations
38. Prognostic value and oncogenic landscape of TP53 alterations in adult and pediatric T-ALL
39. Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
40. Reduced Venetoclax Exposition to Seven Days of Azacitidine Is Efficient in Treatment-Naïve Patients with Acute Myeloid Leukemia
41. DNA Replication Stress Due to Loss of R-Loops in Myelodysplastic Syndromes with SF3B1 Mutation
42. Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era
43. Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis
44. Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein
45. OAB-016: High risk subclones detected at relapse are present from diagnosis in small subclones and impact the prognosis
46. Visceral leishmaniasis: an unusual cause of isolated lymphadenopathy
47. C/EBPα confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress in FLT3-mutant leukemia
48. Additional file 1 of Antimicrobial stewardship in high-risk febrile neutropenia patients
49. Additional file 1 of Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell level
50. Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.